Hypertension strengthens δ-ALA-D activity inhibition and increases it reactivation index in type 2 diabetic patients

Journal of Diabetes and Its Complications
Gabriela BonfantiThissiane L Gonçalves

Abstract

To assess the effect of hypertension on δ-aminolevulinate dehydratase (δ-ALA-D) activity of type 2 diabetic patients (T2DM). δ-ALA-D activity and reactivation index, as well as markers of oxidative stress, biochemical and anthropometrics parameters were determined in T2DM (n=23), type 2 diabetic patients with hypertension (T2DM/HT) (n=30) and controls (n=30). T2DM/HT presented a greater inhibition of δ-ALA-D activity, a higher reactivation index (p<0.05) and a greater depletion of plasma protein thiol groups (P-SH) when compared to T2DM. Moreover, δ-ALA-D activity was positively associated with SH groups and negatively associated with serum protein carbonyl (PC) while its reactivation index was negatively associated with SH groups and positively associated with PC. These results point out that there is a possible interference of hypertension on the mechanism of the δ-ALA-D activity suggesting that this condition aggravated the oxidative stress of diabetes mellitus.

References

Feb 5, 1976·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D Shemin
Jan 1, 1979·Circulation·W B Kannel, D L McGee
Jan 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R J Jarrett
Aug 1, 1985·Archives of Biochemistry and Biophysics·L H Lash, D P Jones
Apr 1, 1972·Analytical Biochemistry·A F Boyne, G L Ellman
Jan 1, 1996·Free Radical Biology & Medicine·H F GalleyN R Webster
Oct 16, 1999·Hypertension·M McIntyreA F Dominiczak
Dec 3, 1999·Metabolism: Clinical and Experimental·E C OparaS Abdel-Aleem
Jun 15, 2000·Journal of Human Hypertension·F ContrerasM Velasco
Jun 28, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Antonio FontanellasRafael Enríquez de Salamanca
Dec 31, 2002·Archives of Biochemistry and Biophysics·Maria E M RochaEtelvino J H Bechara
Nov 29, 2005·Clinical Biochemistry·Aleksandra JurekAndrzej Klein
Feb 13, 2007·Clinical Biochemistry·João B SouzaMaria R C Schetinger
Mar 6, 2007·Diabetes Research and Clinical Practice·Agnieszka PiwowarMaria Warwas
Nov 23, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Maísa de Carvalho CorrêaMaria Rosa Schetinger
Jan 2, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Juliana ValentiniSolange C Garcia
Jan 29, 2009·Thrombosis Research·Daniéle Sausen LunkesVera Maria Morsch
May 19, 2010·Internal and Emergency Medicine·Alberto MilanFranco Veglio
Oct 29, 2010·International Journal of Hypertension·Kazuko Masuo
Jan 6, 2011·Rejuvenation Research·Víctor Manuel Mendoza-NúñezRosa Elba Galván-Duarte

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.